MENU
IOVA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Iovance Biotherapeutics (IOVA) Earnings Date & Reports

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system’s ability to recognize and destroy diverse cancer cells using therapies personalized for each patient... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

IOVA is expected to report earnings to fall 20.20% to -19 cents per share on March 03

Iovance Biotherapeutics IOVA Stock Earnings Reports
Q4'25
Est.
$-0.20
Q3'25
Beat
by $0.01
Q2'25
Missed
by $0.05
Q1'25
Missed
by $0.12
Q4'24
Beat
by $0.01
The last earnings report on November 06 showed earnings per share of -25 cents, beating the estimate of -26 cents. With 11.33M shares outstanding, the current market capitalization sits at 956.69M.
View a ticker or compare two or three
IOVA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IOVA showed earnings on November 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of biotechnological products for the treatment of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
825 Industrial Road
Phone
+1 650 260-7120
Employees
557
Web
https://www.iovance.com